Clinical Report: Infections Caused by Mycoplasma hominis in Deep Sternal Wound Complications
Overview
This report reviews three cases of deep sternal wound infections (DSWIs) caused by Mycoplasma hominis following cardiac surgery. The findings highlight the challenges in diagnosing and managing these infections, which can lead to significant postoperative complications.
Background
Deep sternal wound infections (DSWIs) are serious complications following cardiac surgery, often linked to various risk factors such as diabetes and obesity. Mycoplasma hominis, typically associated with urogenital infections, has emerged as an opportunistic pathogen in postoperative settings, particularly in immunocompromised patients. Understanding the clinical implications of M. hominis in DSWIs is crucial for improving patient outcomes and infection management strategies.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
Mycoplasma hominis can cause DSWIs in patients undergoing cardiac surgery, despite being an uncommon pathogen.
All three reported cases involved elective surgeries with sternotomy, highlighting the need for vigilance in postoperative monitoring.
Diagnosis of M. hominis infections can be challenging due to negative Gram stains and slow growth on routine media.
Effective management included tailored antibiotic therapy and surgical interventions such as debridement and vacuum sealing drainage.
Procalcitonin and C-reactive protein levels were useful in monitoring infection progression and treatment response.
Clinical Implications
Healthcare professionals should consider Mycoplasma hominis as a potential pathogen in patients with DSWIs, especially when conventional cultures yield negative results. Early identification and appropriate antibiotic therapy are essential for improving patient outcomes in these complex cases.
Conclusion
The cases presented underscore the importance of recognizing Mycoplasma hominis as a potential cause of DSWIs after cardiac surgery. Enhanced awareness and tailored management strategies are necessary to address these challenging infections.
